Gästebuch » Detroit Lions Hats

WASHINGTON Authentic A. J. Cann Jersey , Dec. 15 (Xinhua) -- The number of clinical trials funded by the U.S. government has fallen substantially, while the number of industry-sponsored trials has increased dramatically since 2006, according to a study published Tuesday that led researchers to call for a discussion on how to best allocate U.S. health research budgets.


"My concern is that independent trials are on the decline and that means we have less high-quality data to inform public health that are not influenced by commercial interests," study leader Stephan Ehrhardt, an associate professor in the Johns Hopkins Bloomberg School of Public Health Authentic Dante Fowler Jr Jersey , said in a statement.


"When I am doing a government-funded trial comparing two treatments, I start with the assumption that both treatments are equal. I don't have a vested financial interest in the outcome," Ehrhardt said.


"But when I am a drug company testing my new product, my objectivity can be compromised by the company's bottom line since it costs me millions of dollars to develop and test my product to get it on the market. It might be difficult for me to be completely objective. The stakes are very high," he said.


In the U.S. Authentic Yannick Ngakoue Jersey , the National Institutes of Health (NIH) and the pharmaceutical industry have been major funders of trials.


In general, pharmaceutical companies fund trials that test their own products, whereas the NIH's funding strategies are not commercially motivated. Results from NIH-funded trials often provide the basis for prevention and treatment recommendations.


For the study, Ehrhardt and his colleagues searched the NIH-built database, ClinicalTrials.gov Authentic Myles Jack Jersey , for "interventional study" and then searched by funder type for trials registered between 2006 and 2014.


The number of newly registered industry-sponsored trials increased 43 percent over the time period from 4,585 in 2006 to 6,550 in 2014. The number of newly registered NIH-funded trials decreased 24 percent over the same period from 1,376 in 2006 to 1,048 in 2014.


Both NIH and industry trials are required to be registered if researchers intend to publish the results